Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

https://doi.org/10.1016/0960-0760(96)00048-9Get rights and content

Abstract

Vitamin D derivatives have been shown both to inhibit the proliferation of cultured breast cancer cells and to cause regression of experimental mammary tumours in vivo. We have investigated the ability of several vitamin D analogues to promote the regression of experimental rat mammary tumours. Our results revealed that one vitamin D compound in particular, EB1089 (1(S),3(R)-dihydroxy-20(R)-5′-ethyl-5′-hydroxy-hepta-1′(E),3′(E)-dien-1′-yl)-9,10-secopregna-5(Z),7(E),10(19)-triene), was highly effective at inhibiting tumour progression, without causing a significant rise in serum calcium concentration. Tumour regression occurs when the rate of cell death is greater than the rate of cell proliferation. Apoptosis (programmed or active cell death) is an active, energydependent process in which a distinct series of biochemical and molecular events leads to the death of cells by specific signals. We have examined effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and the synthetic vitamin D analogue EB1089 on indices of apoptosis in cultured human breast cancer cells. The effects of the vitamin D compounds on the expression of two oncoproteins which may regulate apoptosis, bcl-2 and p53 were examined by Western analysis. In MCF-7 cell cultures treated for six days with 1,25(OH)2D3 or EB1089 (1 × 10−8 M), bcl-2 protein was reduced in comparison to control levels, whereas p53 protein was increased. In addition, the p21 protein, whose gene WAF-1 is induced by wild type p53, was also increased by both vitamin D compounds. Using Northern analysis, it was observed that 24-h treatment of MCF-7 cells with 1 × 10−8 M 1,25(OH)2D3 or EB1089 resulted in an induction of TRPM-2 (clusterin) mRNA, a gene associated with onset of apoptosis in the involuting prostate. Fragmentation of genomic DNA is a characteristic feature of apoptosis. With the terminal deoxynucleotidyl transferase (TdT) assay, 3′-OH DNA breaks indicative of DNA fragmentation were detected histochemically in MCF-7 cells treated with 1 × 10−8 M 1,25(OH)2D3 or EB1089 for four days prior to fixation and TdT reaction. Further evidence of apoptosis was obtained following six days treatment of MCF-7 cell cultures with 5 × 10−8 M 1,25(OH)2D3 or EB1089, utilizing a cell death ELISA assay, which measures the presence of histone-associated oligonucleosome complexes generated from DNA fragmentation. Taken together our findings indicate that vitamin D derivatives may play a role in regulating the expression of genes and protein products implicated in apoptosis.

References (38)

  • J.A. Eisman et al.

    Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers

    Cancer Res.

    (1986)
  • J. Abe et al.

    A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia

    Endocrinology

    (1991)
  • A.H. Wyllie

    Apoptosis: cell death in tissue regulation

    J. Pathol.

    (1987)
  • M.J. Arends et al.

    Apoptosis: the role of the endonuclease

    Am. J. Pathol.

    (1990)
  • F. Yonish-Rouach et al.

    Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6

    Nature

    (1991)
  • P. Shaw et al.

    Induction of apoptosis by wild type p53 in a human colon tumour derived cell line

  • Y. Barak et al.

    mdm2 expression is induced by wild-type p53 activity

    EMBO J.

    (1993)
  • W.S. El-Diery et al.

    WAF1, a potential mediator of p53 tumour suppression

    Cell

    (1993)
  • W.S. El-Deiry et al.

    WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

    Cancer Res.

    (1994)
  • Cited by (0)

    View full text